Medication info
Lipostone 20 mg (Rosuvastatin Calcium)

Lipostone 20 mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
KOREA Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201504162 · Approved 2015.06.26 · Insurance code 642802750

Summary

Main use
Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of the progression of atherosclerosis
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate based on LDL cholesterol levels, treatment goals, and patient response, at intervals of 4 weeks or longer, and may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
Children's dosage
Ages 10 ∼ 17 years: The usual dose range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) Ages 10 ∼ 17 years: The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Ingredients

Manufacturer
KOREA Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of dyslipidemia, reduction of cardiovascular disease risk, and inhibition of the progression of atherosclerosis

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • dysbetalipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary heart disease
  • stroke risk
  • myocardial infarction risk
View approved original text

This medication is primarily used as an adjunct to diet for patients with primary hypercholesterolemia and mixed hyperlipidemia who are not adequately controlled by diet and exercise alone. It is also applied as an adjunct with other lipid-lowering therapies for patients with homozygous familial hypercholesterolemia. This drug helps lower cholesterol levels and delays the progression of atherosclerosis. It is particularly used in pediatric patients aged 10 to 17 years with heterozygous familial hypercholesterolemia and effectively reduces total cholesterol and LDL cholesterol. Additionally, it is utilized as an adjunct to diet in patients with dysbetalipoproteinemia and helps lower the risk of stroke, myocardial infarction, and revascularization in patients at high risk for cardiovascular disease. It is effectively used in various forms of hyperlipidemia and in reducing the risk of cardiovascular diseases.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), combined hyperlipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. The dose may be adjusted to a maintenance dose if a greater reduction in LDL cholesterol is needed. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate based on LDL cholesterol levels, treatment goals, and patient response, at intervals of 4 weeks or longer, and may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is necessary. 4. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Particular caution is required when administering 20mg of this medicine to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or below, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score above 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.

Children's dosage

Ages 10 ∼ 17 years: The usual dose range is 5 milligrams ∼ 20 milligrams once daily. (There are no clinical data on administration of doses higher than 20 milligrams in pediatric patients.) Ages 10 ∼ 17 years: The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or longer. Under 10 years: Safety and efficacy have not been established.

Precautions

This medication should not be used in certain patients. For example, patients who are allergic to this medication, those with severe liver dysfunction, those with myopathies, and pregnant or breastfeeding women should not take this medication. Furthermore, the use of this drug may be restricted in patients with severely impaired kidney function or those taking certain medications concurrently. Patients at higher risk of muscle-related side effects should avoid high doses of this medication. It is important to regularly monitor liver function and muscle condition while taking this medication. Individuals with a history of liver disease or those who consume alcohol excessively should exercise increased caution, as should those with hypothyroidism or other muscle disorders. If symptoms such as myalgia, muscle weakness, or muscle cramps occur, the physician should be notified immediately, and the medication may need to be discontinued if necessary. Additionally, it is advisable to avoid performing muscle enzyme tests after intense exercise while on this medication. This medication can raise blood sugar levels in some patients, so individuals at risk of diabetes must strictly manage their blood glucose levels. Rarely, serious allergic reactions or liver dysfunction may occur; therefore, if symptoms such as skin rashes, jaundice, or severe fatigue develop, treatment should be stopped immediately and consultation with healthcare professionals should occur. This medication may interact with other drugs, so it is essential to inform the doctor or pharmacist of any currently taken medications. Caution is especially needed when used with certain antiviral, immunosuppressive, antibiotic, or fibrate drugs. Women of childbearing potential should ensure proper contraceptive measures before taking this medication, and it should be avoided during pregnancy. Its use is also not recommended while breastfeeding. In case of overdose, there is no specific antidote, so one must go to the hospital immediately for treatment according to symptoms and monitor liver function and muscle enzyme levels. Finally, while this medication is not known to significantly affect driving or machinery operation, it can rarely cause dizziness, so caution is advised.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, asthenia, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculomotor weakness, thrombocytopenia, jaundice, hepatitis, increased transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms (DRESS), lichenoid drug eruption, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, fatigue, numbness, paresthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture and should ideally be kept at room temperature between 1°C and 30°C. Storing it this way helps maintain the medication's effectiveness over time.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.